Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/27/2009

attributable to common shareholders - basic $0.10 $0.03 $0.24 $0.15 Earnings per share attributable to common shareholders - diluted $0.07 $0.02 $0.15 $0.09 CUMBERLAND PHARMACEUTICALS INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Six Months Ended June 30, ------------------------- 2008 2009 ---- ---- Cash flows from operating activities: Net income $2,453,673 $1,493,266 Adjustments to reconcile net income to net cash flows from operating activities: Gain on early extinguishment of other long-term obligations (38,577) - Depreciation and amortization expense 392,896 398,341 Nonemployee stock granted for services received 27,500 182,091 Nonemployee stock option grant expense - 826,290 Stock-based compensation - employee stock options 121,725 313,064 Excess tax benefit derived from exercise of stock options (156,758) (2,842,825) Noncash interest expense 63,113 29,376 Net changes in assets and liabilities affecting operating activities: Accounts receivable (627,785) (125,024) Inventory
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
2. Cumberland Pharmaceuticals Announces Appointments
3. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... TROY Healthcare Solutions is proud to ... User Group (RUG) Conference in Baltimore, MD from May ... User Group provides an opportunity for clients to gather ... gallery. , In addition to sponsoring the event, TROY ... Atlantic RUG Conference. Attendees can stop by the TROY ...
(Date:5/4/2015)... The opportunity for children to dream of ... motivating forces behind The Fairy Godmother Next Door, a new ... L. Stark. , The inspiration for the enchanting story of ... from Stark’s desire to be a fairy godmother. , “My ... to my neighbors’ children since they were born. We discuss ...
(Date:5/4/2015)... METTLER TOLEDO has announced an ... Integrity in a GXP Regulated Laboratory ", featuring ... webinar will be presented on May 27, 2015 ... is a critical component of pharmaceutical product quality ... in recent years an increasing number of inspections ...
(Date:5/4/2015)... May 04, 2015 Ticket Down is a ... Champions Cup (ICC) . While the World Cup is ... held every four years, the International Champions Cup is one ... saw the all-time attendance record for soccer in the United ... Big House at the University of Michigan. This year, the ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2
... of hospital-acquired infections from methicillin-resistant Staphylococcus aureus (MRSA), it ... major hospital trusts // in an attempt to restrict ... NHS Trust is one of the three health care ... Government scheme that would provide tips to combat the ...
... of about 20% of the women who have attained the childbearing ... across the US involving several thousand women. //In the case of ... women belonging to the 16 years to 49 years age group, ... ,The Illinois Chapter of the Sierra Club’s Jack Darin has termed ...
... If appropriate steps are not taken to restrict spread of ... more than 18 million African children would be orphaned // ... 20% increase in just 4 years time. ,The ... by more than 150 health professionals and Government authorities from ...
... The manufacturer of the experimental AIDS drug GS 9137 Gilead ... experiments were successful, as lower levels of HIV were noticed ... // The experiment was conducted over a period of 10 ... effects were also not seen to be of a serious ...
... it disagreed with several provisions of the President's 2007 ... transfer of ownership of oxygen equipment to the beneficiary ... health reimbursement are being opposed by the Association. ... the American Association for Homecare and CEO of Homecare ...
... and Quality has reported that more than $726 million , ... billed to Medicare or Medicaid, government programs intended for the ... statistics, the average charge is $59,600 for Medicare patients and ... burn victims with private insurance is $41,400; and ...
Cached Medicine News:Health News:NHS Trust Would Soon Take On The Hospital Superbug 2Health News:The AIDS Pandemic May Orphan 18 Million African Children By 2010 2
(Date:5/4/2015)... 2015 RadiologyAuction will have their first auction starting ... demonstrations at the end of the auction on May ... and Fuji Cr,s, Agfa and Sony, printers and GE ... Various imaging equipment will be available at later auctions ... years of buying and selling imaging equipment, the brokers ...
(Date:5/4/2015)...  Oncobiologics, Inc., a biotherapeutics company focused on ... completed the construction of its GMP commercial launch ... Cranbury, New Jersey . The ... to utilize multiple technologies that enable rapid deployment ... use of the latest single-use technologies, the facility ...
(Date:5/4/2015)... Calif. , May 4, 2015  Isis Pharmaceuticals, ... exclusive license agreement with Bayer HealthCare (Bayer) to develop ... thrombosis. Under the terms of the agreement, Isis is ... payments, including an immediate $100 million up-front payment and ... following a Phase 2 study in patients with compromised ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... -- Clinilabs, an early phase and specialty CRO that ... today announced that they have opened a second Phase ... 15,000 square foot Specialty Pharma Phase I Unit features ... bioanalytic laboratory, pharmacy, and exam rooms. Since ...
... Inc. (NASDAQ: GNVC ) announced today that on ... of its common stock to Cynthia Collins, its newly appointed ... by the Compensation Committee of GenVec,s Board of Directors and ... material to Ms. Collins,s acceptance of employment with GenVec in ...
Cached Medicine Technology:Clinilabs Opens Phase I Unit In Eatontown, New Jersey 2GenVec Reports Inducement Award 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: